# Rosuvastatin

## Crestor 10mg

| 藥物代碼           | OCRE                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
|:-------------------|:----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 適應症             | Treatment of primary hypercholesterolaemia (type IIa including heterozygous familial hypercholesterolaemia) or mixed dyslipidaemia (type IIb) as an adjunct to diet when response to diet & other non-pharmacological measures are inadequate. Treatment of homozygous familial hypercholesterolaemia, either alone or as an adjunct to diet & other non-pharmacological (e.g. exercise, weight reduction) is inadequate. Homozygous familial hypercholesterolaemia as an adjunct to diet and other lipid lowering treatments (e.g. LDL apheresis) or if such treatments are not appropriate. |
| 副作用             | Constipation, nausea, abdominal pain, headache, dizziness, myalgia, asthenia.Gastrointestinal: Abdominal pain (2.4% ), Nausea (2% to 3.4% )Musculoskeletal: Arthralgia (10.1% ), Myalgia (2.8% to 12.7% , )Neurologic: Asthenia (0.9% to 4.7% ), Headache (3.1% to 5.5% )Renal: Urinary tract infectious disease (2.3% .)                                                                                                                                                                                                                                                                     |
| 禁忌               | Active liver disease including unexplained, persistent elevations of serum transaminases & any serum transaminase elevation exceeding 3 times the upper limit of normal; severe renal impairment (creatinine clearance <30 mL/min), myopathy; patients on concomitant cyclosporin; pregnancy & lactation.                                                                                                                                                                                                                                                                                     |
| 藥物保存方式       | 室溫                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| 用法用量           | Initially 10 mg once daily, max; 20 mg/day                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| 肝功能異常         | 需 調 整 劑 量  ALT或AST持續超過UTN之3倍以上,則建議降低劑量或停藥                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| 腎功能異常         | 需 調 整 劑 量                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| 懷孕用藥危分級     | 不可使用                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| 孕期用藥建議       | Contraindicated - 1st trimester                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| 附帶說明           | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| 哺乳期用藥建議     | Contraindicated 哺乳期使用禁忌                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| 附帶說明           | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| 注射劑給藥建議途徑 | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| 乾粉稀釋液         | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| 輸注點滴液         | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| IVP 用法建議       | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| IVD 用法建議       | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| 注意事項           | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |

